Literature DB >> 19003306

Serum-free produced Bovine Herpesvirus type 1 and Bovine Parainfluenza type 3 virus vaccines are efficacious and safe.

B Makoschey1, J R Patel, P T J A van Gelder.   

Abstract

The studies described in this report were performed to determine, whether it is possible to produce live virus vaccines without serum or fractions thereof used during any cell or virus passage, thus completely serum-free. Two viruses were included in the experiments: Bovine Herpesvirus 1 (BHV-1) and Bovine Parainfluenza type 3 virus (PI3). Both viruses were found to grow to satisfactory titers, and to be stable after freeze-drying and subsequent storage at temperatures of +4 degrees C and -20 degrees C for at least one year. Moreover, a vaccine containing serum free produced BHV-1 was tested in a vaccination-challenge experiment. For comparison, a vaccine batch with BHV-1 grown in serum-containing cell culture medium was included in the study. Both vaccine preparations performed equally well and both met the strict requirements as laid down in the European Phamacopeia. Moreover, in two separate experiments the safety of serum-free produced BHV-1 and PI3 after overdose and repeated administration even in very young calves and even after four administrations has been demonstrated. This report is the first, which to our knowledge demonstrates the safety and efficacy of serum-free produced live vaccines in the target animal as well as the stability of these products.

Entities:  

Year:  2002        PMID: 19003306      PMCID: PMC3449637          DOI: 10.1023/A:1023982003258

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  27 in total

Review 1.  The development, benefits and disadvantages of serum-free media.

Authors:  S J Froud
Journal:  Dev Biol Stand       Date:  1999

Review 2.  Safety issues of animal products used in serum-free media.

Authors:  O W Merten
Journal:  Dev Biol Stand       Date:  1999

3.  Bovine viral diarrhea disease associated with a contaminated vaccine.

Authors:  E Falcone; M Tollis; G Conti
Journal:  Vaccine       Date:  1999-10-14       Impact factor: 3.641

4.  Collective experiences of adventitious viruses of animal-derived raw materials and what can be done about them.

Authors:  S J Wessman; R L Levings
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

5.  Sequence analysis of the 5' untranslated region of pestivirus RNA demonstrated in interferons for human use.

Authors:  R Harasawa; T Sasaki
Journal:  Biologicals       Date:  1995-12       Impact factor: 1.856

6.  Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polymerase chain reaction.

Authors:  A Kappeler; C Lutz-Wallace; T Sapp; M Sidhu
Journal:  Biologicals       Date:  1996-06       Impact factor: 1.856

7.  Production of influenza virus in serum-free mammalian cell cultures.

Authors:  O W Merten; J C Manuguerra; C Hannoun; S van der Werf
Journal:  Dev Biol Stand       Date:  1999

8.  Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation.

Authors:  J Kurth; R Waldmann; J Heith; K Mausbach; R Burian
Journal:  Dev Biol Stand       Date:  1999

9.  Replacement of serum in cell culture by hormones: a study of hormonal regulation of cell growth and specific gene expression.

Authors:  R Wu; G H Sato
Journal:  J Toxicol Environ Health       Date:  1978 Mar-May

10.  Production of recombinant proteins in Chinese hamster ovary cells using a protein-free cell culture medium.

Authors:  M Zang; H Trautmann; C Gandor; F Messi; F Asselbergs; C Leist; A Fiechter; J Reiser
Journal:  Biotechnology (N Y)       Date:  1995-04
View more
  3 in total

1.  Introduction to animal cell culture technology-past, present and future.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2006-08-03       Impact factor: 2.058

2.  Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein.

Authors:  Masami Mochizuki
Journal:  Vaccine       Date:  2005-10-25       Impact factor: 3.641

3.  Virus contaminations of cell cultures - A biotechnological view.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.